FDA Brief

Warning letters Food

FDA warning letter to

The Elderberry Fairy & Co., LLC

LowIssued Aug 15, 2022Posted Aug 30, 2022Office of Human and Animal Food Operations East Division 6

FDA warns The Elderberry Fairy & Co. that elderberry syrups and Organic Fire Cider are unapproved new drugs and misbranded.

What happened

In June 2022, FDA reviewed the company's website and Facebook page, which directs consumers to the website to buy products. FDA found claims that Elderberry Syrup with Honey, Elderberry Syrup with Agave, and Organic Fire Cider prevent or treat colds, flu, allergies, sinus infections, and other conditions. FDA says those claims make the products drugs, but they are not FDA-approved and lack adequate directions for use.

What FDA found

  1. Website and social media claims say the elderberry syrups and Organic Fire Cider treat or prevent diseases such as colds, flu, allergies, and sinus infections, so FDA treats them as drugs.

    section 201(g)(1)(B) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. 321(g)(1)(B)]
  2. FDA calls the products 'new drugs' because they are not generally recognized as safe and effective for the claimed uses and lack FDA approval.

    sections 201(p), 301(d), and 505(a) of the Act [21 U.S.C. 321(p), 331(d), 355(a)]
  3. FDA says the products are misbranded because they lack adequate directions for a layperson to use them safely for the claimed disease uses.

    section 502(f)(1) of the Act [21 U.S.C. 352(f)(1)]; 21 CFR 201.5
  4. Selling these misbranded drugs in interstate commerce violates the Act.

    section 301(a) of the Act [21 U.S.C. 331(a)]

What FDA wants

Within 15 working days of receipt, notify FDA in writing of the specific steps taken to address the violations, including how recurrence will be prevented and related documentation; if corrections cannot be completed, state the reason and completion time.

Who should pay attention

  • small food and supplement brands making disease claims online
  • retailers and marketplaces selling elderberry or herbal syrups
  • companies using social media posts to promote health products

This is a summary. Read the original letter on fda.gov.

Similar letters to other companies

  1. Natuzem

    FDA warned Mexico-based Natuzem for selling unapproved new drugs, including Reumofan Plus, to U.S. consumers online.

    High risk
  2. RonanRx, Inc. dba RonanRx

    FDA says RonanRx's website and X posts misbrand compounded semaglutide and tirzepatide with false or misleading claims.

    Low
  3. Calibrate IV Hydration

    FDA told Calibrate IV Hydration its umbilical cord and exosome IV products are unapproved drugs and unlicensed biologics.

    High risk
  4. Best Chinese Medicines LLC

    FDA warned Best Chinese Medicines LLC that five herbal products sold online are unapproved new drugs because their labeling claims to treat diseases.

    High risk